Strata Critical Medical, Inc. (SRTAW) support and resistance · rev $248.7M
Strata Critical Medical, Inc. (SRTAW) common stock listed on NASDAQ.
This page maps Strata Critical Medical, Inc. (SRTAW) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported SRTAW revenue for 2024-12-31 was $248.7M. Net income was -$27.3M. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. SRTAW currently screens at market cap $0.
SRTAW currently screens at market cap $0. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new SRTAW 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the SRTAW quote page for the session range and the stock page for the full model.
Not investment advice.